Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear factor erythroid 2-related factor 1 (NFE2L1), also known as Nrf1, is a transcription factor. It belongs to the cap ‘n’ collar (CNC) subfamily of basic leucine zipper (bZIP) transcription factors. NFE2L1 is ubiquitously expressed and primarily located at the endoplasmic reticulum membrane under basal conditions. In response to cellular stresses, it undergoes cleavage, translocates into the nucleus, and acts as an active transcription factor. It plays roles in oxidative stress response, proteostasis, metabolism, cell differentiation, and inflammation. Cytoplasmic and nuclear localization patterns are associated with clinical features in diseases like diffuse large B cell lymphoma.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor erythroid 2-related factor 1 (Nrf1).